In Japan, we previously reported that severe hepatic fibrosis (F3/4) and PNPLA3 GG are significant factors associated with incident HCC development in Japanese patients with biopsy proven NAFLD [56]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.